KR100609813B1 - 결핵 예방 백신 - Google Patents
결핵 예방 백신 Download PDFInfo
- Publication number
- KR100609813B1 KR100609813B1 KR1020050015561A KR20050015561A KR100609813B1 KR 100609813 B1 KR100609813 B1 KR 100609813B1 KR 1020050015561 A KR1020050015561 A KR 1020050015561A KR 20050015561 A KR20050015561 A KR 20050015561A KR 100609813 B1 KR100609813 B1 KR 100609813B1
- Authority
- KR
- South Korea
- Prior art keywords
- protein
- ag85a
- tuberculosis
- esat
- vaccine
- Prior art date
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/04—Mycobacterium, e.g. Mycobacterium tuberculosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
- A61K2039/507—Comprising a combination of two or more separate antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
- A61K2039/522—Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Mycology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Communicable Diseases (AREA)
- Pulmonology (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Abstract
Description
Claims (7)
- 결핵균(Mycobacterium tuberculosis)의 알파-크리스탈린 단백질 (alpha-crystalline protein, 16kDa)을 포함하는 결핵 예방용 백신 조성물.
- 결핵균의 Ag85A 단백질(32kDa)과 ESAT-6(6kDa) 단백질을 포함하는 결핵 예방용 백신 조성물.
- 제2항에 있어서, Ag85A 단백질과 ESAT-6 단백질이 중량을 기준으로 하여 1 대 1로 혼합된 결핵 예방용 백신 조성물.
- 결핵균의 Ag85A 단백질과 포스페이트 결합 단백질 1 (phosphate binding protein 1, 38kDa)을 포함하는 결핵 예방용 백신 조성물.
- 제4항에 있어서, 결핵균의 Ag85A 단백질과 포스페이트 결합 단백질 1이 중량을 기준으로 하여 1 대 1로 혼합된 결핵 예방용 백신 조성물.
- 결핵균의 Ag85A 단백질 , ESAT-6 단백질 및 알파-크리스탈린 단백질을 포함하는 결핵 예방용 백신 조성물.
- 제6항에 있어서, Ag85A 단백질, ESAT-6 단백질 및 알파-크리스탈린 단백질이 중량을 기준으로 하여 1 대 1대 1로 혼합된 결핵 예방용 백신 조성물.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020050015561A KR100609813B1 (ko) | 2005-02-24 | 2005-02-24 | 결핵 예방 백신 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020050015561A KR100609813B1 (ko) | 2005-02-24 | 2005-02-24 | 결핵 예방 백신 |
Publications (1)
Publication Number | Publication Date |
---|---|
KR100609813B1 true KR100609813B1 (ko) | 2006-08-08 |
Family
ID=37185093
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020050015561A KR100609813B1 (ko) | 2005-02-24 | 2005-02-24 | 결핵 예방 백신 |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR100609813B1 (ko) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2009089535A3 (en) * | 2008-01-11 | 2009-10-01 | The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Polypeptide vaccine and vaccination strategy against mycobacterium |
CN113365655A (zh) * | 2019-01-28 | 2021-09-07 | 巴伊沃爱普有限公司 | 包含糖基化ag85a蛋白的用于预防结核病的疫苗组合物及其制备方法 |
-
2005
- 2005-02-24 KR KR1020050015561A patent/KR100609813B1/ko not_active IP Right Cessation
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2009089535A3 (en) * | 2008-01-11 | 2009-10-01 | The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Polypeptide vaccine and vaccination strategy against mycobacterium |
US8741313B2 (en) | 2008-01-11 | 2014-06-03 | Emory University | Polypeptide vaccine and vaccination strategy against mycobacterium |
CN113365655A (zh) * | 2019-01-28 | 2021-09-07 | 巴伊沃爱普有限公司 | 包含糖基化ag85a蛋白的用于预防结核病的疫苗组合物及其制备方法 |
JP2022518807A (ja) * | 2019-01-28 | 2022-03-16 | バイオアプリケーションズ インコーポレイテッド | グリコシル化したag85aタンパク質を含む結核予防用ワクチン組成物およびその製造方法 |
JP7233662B2 (ja) | 2019-01-28 | 2023-03-07 | バイオアプリケーションズ インコーポレイテッド | グリコシル化したag85aタンパク質を含む結核予防用ワクチン組成物およびその製造方法 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Acevedo et al. | Bacterial outer membrane vesicles and vaccine applications | |
Harrison et al. | Correlates of protection induced by live Aro− Salmonella typhimurium vaccines in the murine typhoid model | |
Pal et al. | Immunization with extracellular proteins of Mycobacterium tuberculosis induces cell-mediated immune responses and substantial protective immunity in a guinea pig model of pulmonary tuberculosis | |
Badmasti et al. | Immunological evaluation of OMV (PagL)+ Bap (1-487aa) and AbOmpA (8-346aa)+ Bap (1-487aa) as vaccine candidates against Acinetobacter baumannii sepsis infection | |
US6821521B1 (en) | Multicomponent meningococcal vaccine | |
US10010595B2 (en) | Live recombinant booster vaccine against tuberculosis | |
Dabo et al. | Vaccination with Pasteurella multocida recombinant OmpA induces strong but non-protective and deleterious Th2-type immune response in mice | |
Monaci et al. | MF59-and Al (OH) 3-adjuvanted Staphylococcus aureus (4C-Staph) vaccines induce sustained protective humoral and cellular immune responses, with a critical role for effector CD4 T cells at low antibody titers | |
ES2853773T3 (es) | Procedimientos novedosos para inducir una respuesta inmune | |
CN101600455B (zh) | 预防性结核疫苗 | |
Chen et al. | Comparison of four adjuvants revealed the strongest protection against lethal pneumococcal challenge following immunization with PsaA-PspA fusion protein and AS02 as adjuvant | |
Baker et al. | Intradermal vaccination with a Pseudomonas aeruginosa vaccine adjuvanted with a mutant bacterial ADP-ribosylating enterotoxin protects against acute pneumonia | |
Zhang et al. | Antibody-mediated protection against Staphylococcus aureus dermonecrosis and sepsis by a whole cell vaccine | |
Mobarez et al. | Induction of protective immunity by recombinant peptidoglycan associated lipoprotein (rPAL) protein of Legionella pneumophila in a BALB/c mouse model | |
US10953081B2 (en) | Methods and compositions for inducing an immune response to Pseudomonas aeruginosa pulmonary infections | |
KR100609813B1 (ko) | 결핵 예방 백신 | |
ES2617242T3 (es) | Vacunas de Salmonella no tifoidea | |
WO2016036503A1 (en) | Antigen compositions and methods of use for treating extraintestinal pathogenic e. coli infections | |
Speranza et al. | Recombinant BCG-Rv1767 amount determines, in vivo, antigen-specific T cells location, frequency, and protective outcome | |
US20140023684A1 (en) | Vaccine Against Pasteurellaceae | |
US20220118079A1 (en) | Immunogenic Antigens | |
US7846420B2 (en) | Mycobacterium avium subspecies paratuberculosis vaccines and methods of using the same | |
Harrington | Toward a new vaccine for tuberculosis: Immunogenicity of Mycobacterium tuberculosis culture filtrate proteins in nonhuman primates | |
Ainsworth | Characterization of a live attenauted vaccine for protection against multi drug resistant Acinetobacter baumannii | |
Frencher | Role of Isoprenoid Biosynthesis in Listeria-based Tuberculosis Vaccine Efficacy |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant | ||
FPAY | Annual fee payment |
Payment date: 20120511 Year of fee payment: 7 |
|
FPAY | Annual fee payment |
Payment date: 20130612 Year of fee payment: 8 |
|
FPAY | Annual fee payment |
Payment date: 20140730 Year of fee payment: 9 |
|
FPAY | Annual fee payment |
Payment date: 20150731 Year of fee payment: 10 |
|
FPAY | Annual fee payment |
Payment date: 20160801 Year of fee payment: 11 |
|
FPAY | Annual fee payment |
Payment date: 20171218 Year of fee payment: 12 |
|
LAPS | Lapse due to unpaid annual fee |